Orly Mishan

Chief Business Officer

Ms. Mishan joined Cerevel Therapeutics in 2019 as chief business officer. In this role she will lead corporate development, program management, and technical operations while contributing to the advancement of the company’s strategy.

Previously, Ms. Mishan served at Bain Capital Life Sciences as principal, overseeing investments in biopharmaceutical, medical device, diagnostics, and enabling technology companies. As a founding member of the Life Sciences team, she helped execute the partnership with Pfizer that led to the formation of Cerevel Therapeutics.

Prior to joining Bain Capital Life Sciences, Ms. Mishan was the vice president of corporate strategy at Biogen and spent more than 10 years at Boston Scientific in leadership roles supporting strategy, transaction and restructuring activities, and spearheading the development of the global healthcare services business. She began her career as a business analyst at McKinsey & Company and transitioned to a role in the healthcare industry at Pfizer Pharmaceuticals leading interdisciplinary transaction and product development teams.

Ms. Mishan is an advisor to Bain Capital Life Sciences, and a member of board of directors at Kestra Medical Technologies. She earned a Bachelor of Arts in economics and political science from Columbia University.